Literature DB >> 8636113

Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions.

X Qi1, W Qin, Y Sun, K Kondoh, G A Grabowski.   

Abstract

Saposin C is an essential co-factor for the hydrolysis of glucosylceramide by acid beta-glucosidase in mammals. In addition, prosaposin promotes neurite outgrowth in vitro via sequences in saposin C. The regional organization of these neurotrophic and activation properties of saposin C was elucidated using recombinant or chemically synthesized saposin Cs from various regions of the molecule. Unreduced and reduced proteins were analyzed by electrospray-mass spectrometry to establish the complement of disulfide bonds in selected saposin Cs. Using saposin B as a unreactive backbone, chimeric saposins containing various length segments of saposin B and C localized the neurotrophic and acid beta-glucosidase activation properties to the carboxyl- and NH2-terminal 50% of saposin C, respectively. The peptide spanning residues 22-31 had neurotrophic effects. Molecular modeling and site-directed mutagenesis localized the activation properties of saposin C to the region spanning residues 47-62. Secondary structure was needed for retention of this property. Single substitutions of R and S at the conserved cysteines at 47 or 78 diminished but did not obliterate the activation properties. These results indicate the segregation of neurotrophic and activation properties of saposin C to two different faces of the molecule and suggest a topographic sequestration of the activation region of prosaposin for protection of the cell from adverse hydrolytic activity of acid beta-glucosidase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636113     DOI: 10.1074/jbc.271.12.6874

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Analyses of temporal regulatory elements of the prosaposin gene in transgenic mice.

Authors:  Ying Sun; David P Witte; Peng Jin; Gregory A Grabowski
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning.

Authors:  Raquel Romero; Arvind Ramanathan; Tony Yuen; Debsindhu Bhowmik; Mehr Mathew; Lubna Bashir Munshi; Seher Javaid; Madison Bloch; Daria Lizneva; Alina Rahimova; Ayesha Khan; Charit Taneja; Se-Min Kim; Li Sun; Maria I New; Shozeb Haider; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-26       Impact factor: 11.205

3.  Cloning, expression and map assignment of chicken prosaposin.

Authors:  N Azuma; H C Seo; O Lie; Q Fu; R M Gould; M Hiraiwa; D W Burt; I R Paton; D R Morrice; J S O'Brien; Y Kishimoto
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine.

Authors:  Patrick M Winter; John Pearce; Zhengtao Chu; Christopher M McPherson; Ray Takigiku; Jing-Huei Lee; Xiaoyang Qi
Journal:  J Magn Reson Imaging       Date:  2014-05-06       Impact factor: 4.813

5.  Prosaposin: promoter analysis and central-nervous-system-preferential elements for expression in vivo.

Authors:  Y Sun; P Jin; D P Witte; G A Grabowski
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

6.  Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles.

Authors:  Shadi Abu-Baker; Zhengtao Chu; Ashley M Stevens; Jie Li; Xiaoyang Qi
Journal:  J Cancer Ther       Date:  2012-08

7.  Neurolysosomal pathology in human prosaposin deficiency suggests essential neurotrophic function of prosaposin.

Authors:  Jakub Sikora; Klaus Harzer; Milan Elleder
Journal:  Acta Neuropathol       Date:  2006-10-06       Impact factor: 17.088

8.  Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer.

Authors:  Kombo F N'Guessan; Harold W Davis; Zhengtao Chu; Subrahmanya D Vallabhapurapu; Clayton S Lewis; Robert S Franco; Olugbenga Olowokure; Syed A Ahmad; Jen Jen Yeh; Vladimir Y Bogdanov; Xiaoyang Qi
Journal:  Mol Ther       Date:  2020-06-08       Impact factor: 11.454

9.  Pancreatic cancer: current standards, working towards a new therapeutic approach.

Authors:  Olugbenga Olowokure; Xiaoyang Qi
Journal:  Expert Rev Anticancer Ther       Date:  2014-03-13       Impact factor: 4.512

10.  Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.

Authors:  Ying Sun; Huimin Ran; Matt Zamzow; Kazuyuki Kitatani; Matthew R Skelton; Michael T Williams; Charles V Vorhees; David P Witte; Yusuf A Hannun; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.